🇺🇸 FDA
Pipeline program

610 30mg group

SSGJ-610-BA-I/II-01

Phase 1 small_molecule active

Quick answer

610 30mg group for Asthma is a Phase 1 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Sunshine Biopharma
Indication
Asthma
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials